Michael Plank
Overview
Explore the profile of Michael Plank including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Janke C, Rubio-Acero R, Weigert M, Reinkemeyer C, Khazaei Y, Kleinlein L, et al.
Viruses
. 2024 Oct;
16(10).
PMID: 39459890
This study analyzes immune responses to SARS-CoV-2 vaccination and infection, including asymptomatic cases, focusing on infection risks during the Omicron wave, particularly among high-risk healthcare workers. In the KoCo-Impf study,...
2.
Plank M, Carmiol N, Mitri B, Lipinski A, Langlais P, Capaldi A
Mol Biol Cell
. 2024 Mar;
35(4):ar60.
PMID: 38446618
It is well known that eukaryotic cells create gradients of cAMP across space and time to regulate the cAMP dependent protein kinase (PKA) and, in turn, growth and metabolism. However,...
3.
Castelletti N, Paunovic I, Rubio-Acero R, Beyerl J, Plank M, Reinkemeyer C, et al.
Microbiol Spectr
. 2024 Mar;
12(4):e0288523.
PMID: 38426747
SARS-CoV-2 spreads pandemically since 2020; in 2021, effective vaccinations became available and vaccination campaigns commenced. Still, it is hard to track the spread of the infection or to assess vaccination...
4.
Prelog M, Jeske S, Asam C, Fuchs A, Wieser A, Gall C, et al.
J Clin Virol
. 2023 Dec;
170:105622.
PMID: 38091664
Background: SARS-CoV-2 variants of concern (VOC) may result in breakthrough infections (BTIs) in vaccinated individuals. The aim of this study was to investigate the effects of full primary (two-dose) COVID-19...
5.
Reinkemeyer C, Khazaei Y, Weigert M, Hannes M, Le Gleut R, Plank M, et al.
Viruses
. 2023 Jul;
15(7).
PMID: 37515259
Antibody studies analyze immune responses to SARS-CoV-2 vaccination and infection, which is crucial for selecting vaccination strategies. In the KoCo-Impf study, conducted between 16 June and 16 December 2021, 6088...
6.
Le Gleut R, Plank M, Putz P, Radon K, Bakuli A, Rubio-Acero R, et al.
BMC Infect Dis
. 2023 Jul;
23(1):466.
PMID: 37442952
Background: Population-based serological studies allow to estimate prevalence of SARS-CoV-2 infections despite a substantial number of mild or asymptomatic disease courses. This became even more relevant for decision making after...
7.
Ahmed M, Plank M, Castelletti N, Diepers P, Eser T, Rubio-Acero R, et al.
Diagnostics (Basel)
. 2023 Mar;
13(6).
PMID: 36980332
The currently prevailing variants of SARS-CoV-2 are subvariants of the Omicron variant. The aim of this study was to analyze the effect of mutations in the Spike protein of Omicron...
8.
Ahmed M, Diepers P, Janke C, Plank M, Eser T, Rubio-Acero R, et al.
Front Immunol
. 2022 Dec;
13:1026473.
PMID: 36582222
SARS-CoV-2 vaccine breakthrough infections frequently occurred even before the emergence of Omicron variants. Yet, relatively little is known about the impact of vaccination on SARS-CoV-2-specific T cell and antibody response...
9.
Plank M
Biomolecules
. 2022 Feb;
12(2).
PMID: 35204711
TOR and PKA signaling are the major growth-regulatory nutrient-sensing pathways in . A number of experimental findings demonstrated a close relationship between these pathways: Both are responsive to glucose availability....
10.
Liu W, Patouret R, Barluenga S, Plank M, Loewith R, Winssinger N
ACS Cent Sci
. 2021 Jul;
7(6):954-962.
PMID: 34235256
Sesquiterpenes are a rich source of covalent inhibitors with a long history in traditional medicine and include several important therapeutics and tool compounds. Herein, we report the total synthesis of...